News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Carl Zeiss Meditec AG (AFX.DE) Announces a US Clinical Trial of a New Minimally Invasive, All-Femto Laser Vision Correction Method


4/23/2012 11:37:19 AM

DUBLIN, Calif. & JENA, Germany--(BUSINESS WIRE)--Carl Zeiss Meditec announced its intention to initiate a US clinical trial of the ReLEx smile procedure for the correction of myopia, having received conditional approval for the trial from the US Food and Drug Administration (FDA).

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES